comparemela.com
Home
Live Updates
FDA Grants Fast Track Designation for LYT-200 to Treat Head and Neck Cancers : comparemela.com
FDA Grants Fast Track Designation for LYT-200 to Treat Head and Neck Cancers
Treatment with LYT-200 is currently being assessed in a phase 1/2 adaptive design trial in advanced/metastatic solid tumors and in a phase 1b clinical trial.
Related Keywords
Aleksandra Filipovic ,
Deric Sherman ,
Abbvie Inc ,
Puretech Health ,
Memorial Sloan Kettering Cancer Center ,
National Cancer Institute ,
Fast Track ,
Tech Receives ,
Track Designation ,
comparemela.com © 2020. All Rights Reserved.